Champions Oncology, Inc. (CSBR)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Ronnie Morris M.D. | CEO & Director | 400k | -- | 1966 |
Mr. David Barry Miller M.B.A. | Chief Financial Officer | 260k | -- | 1969 |
Dr. Maria Mancini Ph.D. | Chief Operating Officer | -- | -- | -- |
Mr. Arthur Hanson | Vice President of Technology | -- | -- | -- |
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS | Vice President of Global Marketing | -- | -- | -- |
Dr. Michael Ritchie M.B.A., Ph.D. | Chief Commercial Officer | -- | -- | -- |
Dr. Karin Abarca Heidemann Ph.D. | Executive Vice President of Global Scientific Operations | -- | -- | -- |
Dr. Marianna Zipeto Ph.D. | Executive Vice President of Commercial, Research Services & Partnering | -- | -- | -- |
Champions Oncology, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 210
Description
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Corporate Governance
Upcoming Events
July 16, 2025 at 10:59 AM UTC - July 21, 2025 at 12:00 PM UTC
Champions Oncology, Inc. Earnings Date
Recent Events
March 3, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission